Literature DB >> 12434482

Vogt-Koyanagi-Harada disease.

Russell W Read1.   

Abstract

Vogt-Koyanagi-Harada disease is a chronic, granulomatous systemic autoimmune disease with manifestations in the ocular, central nervous, auditory, and integumentary systems. The target of attack seems to be antigens associated with melanocytes. Patients are usually of Asian, Middle Eastern, Asian Indian, Native American, or Hispanic ethnicity, and complain of neurologic symptoms quickly followed by decreased vision caused by a choroiditis, frequently with exudative retinal detachments. Corticosteroids are the mainstay of therapy, but other immunosuppressive therapy may be required. Complications, including cataract, glaucoma, choroidal neovascular membrane formation, and subretinal fibrosis, may limit final visual acuity.

Entities:  

Mesh:

Year:  2002        PMID: 12434482     DOI: 10.1016/s0896-1549(02)00025-1

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN: 0896-1549


  22 in total

1.  Headache, red eyes, blurred vision and hearing loss. Diagnosis: Vogt-Koyanagi-Harada syndrome.

Authors:  Errol Wei'en Chan; Srinivasan Sanjay; Benjamin Chong Ming Chang
Journal:  CMAJ       Date:  2010-05-17       Impact factor: 8.262

2.  The spectrum of Vogt-Koyanagi-Harada disease in Iran.

Authors:  Alireza Hedayatfar; Seyedeh Maryam Hosseini; Nasser Karimi; Khalil Ghasemi Falavarjani; Negin Badie; Mahsa Zameni; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2017-03-04       Impact factor: 2.031

Review 3.  Magnetic resonance imaging of uveitis.

Authors:  Charles Q Li; Aaron A Cho; Neeraj J Edward; Deepak P Edward; Roman G Fajardo; Mahmood F Mafee
Journal:  Neuroradiology       Date:  2015-04-24       Impact factor: 2.804

4.  Vogt-Koyanagi-Harada disease in an 8-year-old boy.

Authors:  Budi Setiabudiawan; Feti Karfiati; Reni Ghrahani; Gartika Sapartini; Indra Sahril
Journal:  Asia Pac Allergy       Date:  2011-07-28

5.  Headache as an initial manifestation of Vogt-Koyanagi-Harada disease.

Authors:  Abdulrahman Samir Khairallah
Journal:  Saudi J Ophthalmol       Date:  2013-10-14

6.  The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey.

Authors:  Ilknur Tugal-Tutkun; Yilmaz Ozyazgan; Yonca A Akova; Yuksel Sullu; Nurettin Akyol; Merih Soylu; Haluk Kazokoglu
Journal:  Int Ophthalmol       Date:  2006-09-07       Impact factor: 2.031

7.  Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals.

Authors:  Chiharu Iwahashi; Kensuke Okuno; Noriyasu Hashida; Kei Nakai; Nobuyuki Ohguro; Kohji Nishida
Journal:  Jpn J Ophthalmol       Date:  2015-03-26       Impact factor: 2.447

8.  Bilateral retinal detachment in a patient with Vogt-Koyanagi-Harada syndrome.

Authors:  Blake E McGehee; Gregory Chaljub; Rajeev K Shah; Ayetkin Oto; Alwin C Camacho; Rosa A Tang
Journal:  Emerg Radiol       Date:  2005-10-20

9.  Degree, duration, and causes of visual loss in uveitis.

Authors:  O M Durrani; N N Tehrani; J E Marr; P Moradi; P Stavrou; P I Murray
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

10.  Role of intravitreal triamcinolone as an adjuvant in the management of Vogt-Koyanagi-Harada disease.

Authors:  Mayur R Moreker; Sikander A Lodhi; Avinash Pathengay
Journal:  Indian J Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.